MetaLabs Co Ltd
Metalabs Co., Ltd. primarily provides clothing, miscellaneous goods, and accessories in South Korea. The company sell goods, such as cosmetics; operates hospital management support, block chain and virtual currency development services, etc.; and social dating services. The company was formerly known as Avista Inc. and changed its name to Metalabs Co., Ltd. in April 2018. Metalabs Co., Ltd. was f… Read more
MetaLabs Co Ltd (090370) - Total Liabilities
Latest total liabilities as of September 2025: ₩127.02 Billion KRW
Based on the latest financial reports, MetaLabs Co Ltd (090370) has total liabilities worth ₩127.02 Billion KRW as of September 2025.
Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.
MetaLabs Co Ltd - Total Liabilities Trend (2011–2024)
This chart illustrates how MetaLabs Co Ltd's total liabilities have evolved over time, based on quarterly financial data. Explore and compare other companies by total liabilities.
MetaLabs Co Ltd Competitors by Total Liabilities
The table below lists competitors of MetaLabs Co Ltd ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
YSX Tech. Co., Ltd Class A Ordinary Shares
NASDAQ:YSXT
|
USA | $16.96 Million |
|
Pegasus Heights Bhd
KLSE:4464
|
Malaysia | RM7.41 Million |
|
Multi Makmur Lemindo
JK:PIPA
|
Indonesia | Rp23.50 Billion |
|
Arvee Laboratories (India) Limited
NSE:ARVEE
|
India | ₹91.40 Million |
|
Bridgford Foods Corporation
NASDAQ:BRID
|
USA | $9.36 Million |
|
Urban One
NASDAQ:UONE
|
USA | $642.06 Million |
|
Soligenix Inc.
NASDAQ:SNGX
|
USA | $3.70 Million |
|
Pivotree Inc.
PINK:PVTRF
|
USA | $5.66 Million |
Liability Composition Analysis (2011–2024)
This chart breaks down MetaLabs Co Ltd's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 0.47 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 1.74 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.46 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how MetaLabs Co Ltd's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for MetaLabs Co Ltd (2011–2024)
The table below shows the annual total liabilities of MetaLabs Co Ltd from 2011 to 2024.
| Year | Total Liabilities | Change |
|---|---|---|
| 2024-12-31 | ₩53.79 Billion | +39.88% |
| 2023-12-31 | ₩38.45 Billion | +245.51% |
| 2022-12-31 | ₩11.13 Billion | -61.09% |
| 2021-12-31 | ₩28.60 Billion | +21.42% |
| 2020-12-31 | ₩23.56 Billion | -40.64% |
| 2019-12-31 | ₩39.68 Billion | +17.20% |
| 2018-12-31 | ₩33.86 Billion | +77.27% |
| 2017-12-31 | ₩19.10 Billion | -64.17% |
| 2016-12-31 | ₩53.31 Billion | -43.54% |
| 2015-12-31 | ₩94.42 Billion | +5.03% |
| 2014-12-31 | ₩89.90 Billion | +1.63% |
| 2013-12-31 | ₩88.45 Billion | -10.03% |
| 2012-12-31 | ₩98.32 Billion | -3.04% |
| 2011-12-31 | ₩101.40 Billion | -- |